Table 1 Basic characteristic of the study groups
Group C (Controls) total n = 13 | Group D (DMD) total n = 43 | |
|---|---|---|
Age [years] | 16.5 ± 2.4* | 13.8 ± 4.6 |
Weight [kg] | 67.5 ± 11.9* | 47.6 ± 19.9 |
Height [cm] | 176 ± 9* | 147 ± 19 |
Dyspnoea [n (%)] | 0 (0%) | 6 (13.6%) |
Hypertension [n (%)] | 0 (0%) | 3 (6.8%) |
Diabetes [n (%)] | 1 (7.7%) | 0 (0%) |
Corticosteroids [n (%)] | 0 (0%)* | 21 (47.7%) |
ACE-inhibitors [n (%)] | 0 (0%)* | 18 (40.9%) |
ARBs [n (%)] | 0 (0%) | 2 (4.5%) |
β-blockers [n (%)] | 0 (0%) | 8 (18.2%) |
Diuretics [n (%)] | 0 (0%) | 3 (6.8%) |
Stage ambulatory/non-ambulatory [n (%)] | – | 16 (37.2%) / 27 (62.8%) |